Dunn John Michael

Avg. Two Year Performance

(10%) Avg. Purchase Return
(5%) Compound
11% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%< 1%24%(16%)(10%)
Purchase Success Rate1 of 32 of 33 of 31 of 30 of 3
Average Sale Return(< 1%)(6%)(7%)(8%)11%
Sale Success Rate7 of 115 of 118 of 116 of 119 of 11
Other » Other

EVP, New Ventures:

Holdings: 24.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

General Counsel and Secretary:

Holdings: 11.88K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--